Clinical Trials Logo

Venezuelan Equine Encephalitis clinical trials

View clinical trials related to Venezuelan Equine Encephalitis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT00109304 Withdrawn - Clinical trials for Venezuelan Equine Encephalitis

Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Start date: July 2005
Phase: Phase 1
Study type: Interventional

This study is being done to determine the safety and tolerability of a new investigational vaccine referred to as VEE IA/B V3526, which may induce production of specific antibodies in vaccinated humans, and may protect them against infection with the Venezuelan Equine Encephalitis (VEE) Virus.